Abstract | INTRODUCTION:
Absence epilepsy is associated with diffuse spike-and-wave discharges (SWD) on the electroencephalogram (EEG). Recent studies have demonstrated that the primary somatosensory cortex is also implicated in the generation of the SWDs. OBJECTIVE: This study investigated the effects of systemic and local administrations of U-92032 into the brain of Genetic Absence Epilepsy Rats from Strasbourg (GAERS). METHODS: GAERS animals underwent stereotaxic surgery for the placement of EEG recording electrodes and guide cannulas for U-92032 administration into the lateral ventricle (intracerebroventricular [i.c.v.]), upper lips area (S1Ulp) or barrel field area (S1B) of primary somatosensory cortex. Following 7 days of recovery, electrical activity was recorded continuously for 1 h before and 6 h after intraperitoneal (0.25; 1; 5 mg/kg i.p.) or local U-92032 or dimethyl sulfoxide ( DMSO) injections. RESULTS: No changes were detected in the cumulative duration, mean duration, and number of SWDs following i.p. U-92032 injections. Local i.c.v. injections of U-92032 caused a significant decrease in the cumulative duration (i.c.v., 50 and 100 nmol/L), mean duration (i.c.v., 50, 100, and 250 nmol/L), and the number (i.c.v., 250 nmol/L) of SWDs compared to DMSO groups. Intra-cortical (S1Ulp and S1B) U-92032 injections caused a significant decrease in all 3 parameters compared to DMSO groups, as well. CONCLUSION: Intra-cortical injection of U-92032 caused almost complete removal of SWDs in GAERS and i.c.v. administration resulted in a significant reduction. However, systemic i.p. administration did not cause a significant change with the applied -doses.
|
Authors | Hasan Raci Yananli, Mahluga Jafarova Demirkapu, Halil Eren Sakallı, Rezzan Gülhan, Filiz Yılmaz Onat |
Journal | Pharmacology
(Pharmacology)
Vol. 105
Issue 9-10
Pg. 561-567
( 2020)
ISSN: 1423-0313 [Electronic] Switzerland |
PMID | 32101873
(Publication Type: Journal Article)
|
Copyright | © 2020 S. Karger AG, Basel. |
Chemical References |
- Calcium Channel Blockers
- Calcium Channels, T-Type
- Piperazines
- U 92032
- Tropolone
|
Topics |
- Animals
- Calcium Channel Blockers
(administration & dosage, pharmacology)
- Calcium Channels, T-Type
(drug effects, metabolism)
- Disease Models, Animal
- Electrodes, Implanted
- Electroencephalography
- Epilepsy, Absence
(drug therapy, genetics, physiopathology)
- Female
- Infusions, Intraventricular
- Injections, Intraperitoneal
- Male
- Piperazines
(administration & dosage, pharmacology)
- Rats
- Rats, Wistar
- Somatosensory Cortex
(drug effects, physiopathology)
- Tropolone
(administration & dosage, analogs & derivatives, pharmacology)
|